Comparative Study of Tadalafil and Tamsulosin as on therapy For Lower Urinary Tract Symptoms Due To Benign Hyperplasia of Prostate.

Pawar, Devendera Singh; Kumar, Ashok; Singh, Santosh Kumar; Singh, Rajwardhan; Yadav, Lokinder; Mittal, Sakshi

doi:10.9790/0853-1509088184

IOSR

2016

DOI: 10.9790/0853-1509088184

|View full text |Cite

Comparative Study of Tadalafil and Tamsulosin as on therapy For Lower Urinary Tract Symptoms Due To Benign Hyperplasia of Prostate.

Devendera Singh Pawar¹,

Ashok Kumar²,

Santosh Kumar Singh³

et al.

Abstract: Objectives: The U.S. Food and Drug Administration approved tadalafil in 2011 to treat the signs and symptoms of Lower Urinary Tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Shalaby., et al (2013) [19] found statistically significant difference in VAS scores in favour of Tamsulosin group (P = 0.00). Pawar and colleagues (2016)[20] also concluded with same result. For many patient's stent symptoms account for most of the morbidity associated with ureteroscopy.…”

supporting

confidence: 56%

Comparative Study to Evaluate the Effect of Tamsulosin and Solifenacin on DJ Stent Related Symptoms

Rana¹,

Reza²,

Chowdhury³

et al. 2023

Act Sci Otal

View full text Add to dashboard Cite

Background: On patient quality of life, stent-associated symptoms can have a significant impact. Related to indwelling ureteral stents, hematuria, urgency, frequency, dysuria, and both bladder and flank pain are the most prevalent symptoms. Among them low back pain and irritative lower urinary tract symptoms and are more frequent. Because of its importance stent is being kept in situ with varieties of medication despite the stent related symptoms. To relief these symptoms like Tamsulosin, Solifenacin, Alphazosin etc., several alpha-adrenergic blocker and antimuscarinic drugs are used. Tamsulosin and Solifenacin both are not costly as use daily single dose. So combination of Tamsulosin and Solifenacin cost effective and may act as a reliever of stent related symptoms also. Objectives:To evaluate the effect of Tamsulosin and Solifenacin in relieving DJ stent related symptoms. Methodology:This prospective quassi experimental study was performed from November 2016 to April 2018. Patients who placed DJ stent after endoscopic stone management in the Department of Urology, Dhaka Medical College and Hospital recruited as study population. A total of 47 patients who were stented following ureteroscopic lithotripsy were included, allocated purposively into two groups. Group A (Tamsulosin) 24 and and Group B (Solifenacin) 23 patients were selected by purposive sampling technique according to inclusion and exclusion criteria for the study.

show abstract

supporting

confidence: 56%

Comparative Study to Evaluate the Effect of Tamsulosin and Solifenacin on DJ Stent Related Symptoms

Rana¹,

Reza²,

Chowdhury³

et al. 2023

Act Sci Otal

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Comparative Study of Tadalafil and Tamsulosin as on therapy For Lower Urinary Tract Symptoms Due To Benign Hyperplasia of Prostate.

Abstract: Objectives: The U.S. Food and Drug Administration approved tadalafil in 2011 to treat the signs and symptoms of Lower Urinary Tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH

Cited by 1 publication

References 24 publications

Comparative Study to Evaluate the Effect of Tamsulosin and Solifenacin on DJ Stent Related Symptoms

Comparative Study to Evaluate the Effect of Tamsulosin and Solifenacin on DJ Stent Related Symptoms

Contact Info

Product

Resources

About